Details for New Drug Application (NDA): 203559
✉ Email this page to a colleague
The generic ingredient in PREDNISOLONE SODIUM PHOSPHATE is prednisolone sodium phosphate. There is one drug master file entry for this compound. Nineteen suppliers are listed for this compound. Additional details are available on the prednisolone sodium phosphate profile page.
Summary for 203559
| Tradename: | PREDNISOLONE SODIUM PHOSPHATE |
| Applicant: | Edenbridge Pharms |
| Ingredient: | prednisolone sodium phosphate |
| Patents: | 0 |
Pharmacology for NDA: 203559
| Mechanism of Action | Corticosteroid Hormone Receptor Agonists |
Suppliers and Packaging for NDA: 203559
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| PREDNISOLONE SODIUM PHOSPHATE | prednisolone sodium phosphate | SOLUTION;ORAL | 203559 | ANDA | ATLANTIC BIOLOGICALS CORP. | 17856-0815 | 17856-0815-1 | 72 CUP, UNIT-DOSE in 1 BOX, UNIT-DOSE (17856-0815-1) / 5 mL in 1 CUP, UNIT-DOSE |
| PREDNISOLONE SODIUM PHOSPHATE | prednisolone sodium phosphate | SOLUTION;ORAL | 203559 | ANDA | ATLANTIC BIOLOGICALS CORP. | 17856-0815 | 17856-0815-2 | 72 CUP, UNIT-DOSE in 1 BOX, UNIT-DOSE (17856-0815-2) / 10 mL in 1 CUP, UNIT-DOSE |
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | SOLUTION;ORAL | Strength | EQ 10MG BASE/5ML | ||||
| Approval Date: | Dec 20, 2016 | TE: | AA | RLD: | No | ||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | RX | Dosage: | SOLUTION;ORAL | Strength | EQ 20MG BASE/5ML | ||||
| Approval Date: | Dec 20, 2016 | TE: | AA | RLD: | No | ||||
Profile for product number 003
| Active Rx/OTC/Discontinued: | RX | Dosage: | SOLUTION;ORAL | Strength | EQ 15MG BASE/5ML | ||||
| Approval Date: | Feb 6, 2023 | TE: | AA | RLD: | No | ||||
Complete Access Available with Subscription
